🇺🇸 FDA
Patent

US 12318483

Manufacturing of bupivacaine multivesicular liposomes

granted A61KA61K31/445A61K47/14

Quick answer

US patent 12318483 (Manufacturing of bupivacaine multivesicular liposomes) held by Pacira Pharmaceuticals, Inc. expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pacira Pharmaceuticals, Inc.
Grant date
Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/445, A61K47/14, A61K47/24, A61K47/28